Vaginal CO₂ laser therapy for genitourinary syndrome in breast cancer survivors-VagLaser study protocol: a randomized blinded, placebo-controlled trial.

ABSTRACT:

Background

Vaginal CO₂ laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is problematic in these women. The objective of this study is to investigate the effectiveness of vaginal laser treatment for alleviation of genitourinary syndrome of menopause in breast cancer survivors treated with adjuvant endocrine therapy. The secondary objective is to explore the importance of repeated vaginal laser treatment and the long-term effects in this patient population.

Methods

VagLaser consist of three sub-studies; a dose response study, a randomized, participant blinded, placebo-controlled study and

SUBMITTER: Jacobsen S 

PROVIDER: S-EPMC10685468 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature